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Epidemiological studies have demonstrated that tobacco smoke
is a major cause of both cancer and vascular diseases. More
than 3800 chemicals are present in tobacco smoke, which
may cause oxidative stress via biotransformation or by macro-
phage activation. In 1954, Richard Doll and Bradford Hill pub-
lished the first prospective evidence on cigarette smoking and
lung cancer [1,2]. In 1962, Framingham investigators published
data showing that smoking increased the risk of heart disease
[3]. Nevertheless, despite the strong evidence, uncertainty was
manufactured and enlarged. This strategy is a common practice
to reduce the public health implications from epidemiological
findings and was used not only by tobacco companies but also
by other industrial arms, including asbestos and lead factories
[4]. For almost half a century, the tobacco companies hired sci-
entists to dispute first that smokers were at greater risk of dying
of lung cancer; second, the role of tobacco use in heart disease;
and finally, the evidence that environmental tobacco smoke in-
creased disease risk in non-smokers [5,6].
The effect of in-utero exposures on health in childhood
and later in life is a growing area of research interest, with
major public health implications. Children are vulnerable to
the adverse effects of environmental tobacco smoke as their
lungs and immune system are undergoing further develop-
ment. The first publications of detrimental health effects of
parental smoking on children’s respiratory health were pub-
lished in the early 1970s [7]. Exposure to environmental tobac-
co smoke in the first 2 years of life has been estimated in
some European countries by Pattenden et al. [8] and ranged
from 19% in Germany to 70% in Bulgaria.
2. Meta-analytical evidence of early-life
effects
There is pooled evidence that constituents of cigarette smoke
cross the placenta, induce pregnancy complications, reduceintrauterine foetal growth and increase the risk of preterm
delivery (Table 1) [9,10]. Meta-analytical evidence has also
shown increased risk of respiratory and ear infections
[11–13], overweight [14]and an increase in blood pressure
[15] in early life and/or childhood, suggesting that maternal
smoking in pregnancy influences the foetal development of
different organ systems. Indeed, low birth weight and pre-
term delivery are also determinants of health risks later in
life, including childhood asthma [16,17]. A cross-sectional
study of 11,500 participants of 8–11-year-old children showed
that prenatal exposure to cigarette smoke has a stronger ef-
fect on childhood asthma compared with postnatal smoke
[18]. Prenatal exposure to maternal smoking without subse-
quent postnatal exposure to environmental tobacco smoke
was related to the presence of asthma at school age with an
odds ratio (OR) of 1.8 (95%CI: 1.1–2.9) [18].
Parental smoking increases the risk of acute lower respira-
tory tract diseases in children [12,13]. The pooled estimates
showed a higher risk in association with smoking by the
mother (OR: 1.56, 95%CI: 1.51–1.62) than with smoking by
the father (OR: 1.31, 95%CI: 1.20–1.42) [12]. The higher risk re-
lated to the mother’s smoking could be explained by the fact
that young children usually spend more time with their
mother or by the interplay with maternal smoking during
pregnancy. In addition to lower respiratory tract infections
(OR: 1.51 95%CI: 1.44–1.52), exposure to environmental tobac-
co smoke has been associated with an increased risk of otitis
media (OR: 1.32, 95%CI: 1.14–1.52) [12].
Exposure to prenatal tobacco increases the level of genetic
damage in newborns and children. A meta-analysis per-
formed in children exposed to environmental tobacco smoke
showed that children and newborns had, respectively, 1.3 and
6.7 times higher levels of haemoglobin adducts compared
with non-exposed newborns [19]. Available meta-analytical
evidence of an association between in-utero exposure to to-
bacco smoke from the parents and childhood cancer seems
weak. Maternal smoking was estimated as an increased riskepenbeek,
Table 1 – Meta-analytical evidence of early-life exposure to cigarette smoke.
Disease Author/Year (population) Design N articles N Pooled Estimate
Placenta previa Castles et al. [9]
(North America, Western Europe)
Case–control
Cohort
6 50.695 Patients 1.58 (1.04–2.12)a
Abruptio placenta 8 57.302 1.62 (1.46–1.77)a
Ectopic pregnancy 9 10.632 1.77 (1.31–2.22)a
Preterm PROMc 6 34.668 1.7 (1.18–2.25)a
Pre-eclampsia 5 4.451 0.51 (0.38–0.64)a
Preterm delivery
(>32 weeks but
<37 weeks of gestation)
Shah et al. [10] (Europe, North
America)
Case–control 20 Cases: >100.000 1.27 (1.21–1.33)a
0-10 Cig/Day: 1.25 (1.12–1.38)a
11-20 Cig/Day: 1.38 (1.23–1.55)a
>1 Pack/Day: 1.31 (1.19–1.45)a
Acute lymphoblastic
Leukaemia (Childhood)
Boffeta et al. [20] (Europe, North
America)
Case–control 4 Primary Not Given Paternal smoking during pregnancy1.17 (0.96–
1.42)b
Milne et al. [23] (Europe, North
America, Australia)
11 Cases: 1994 Paternal smoking around the time of
conception1.15 (1.06–1.24)a
Acute otitis media Moritsugu et al. [12] (Europe, North
America, Australia, Asia, Africa)
3 Primary Not Given Smoking by Either Parent0.99 (0.70–1.40)a
Asthma Moritsugu et al. [12] (Europe, North
America, Australia, Asia, Africa)
31 Primary Not Given Asthma
Smoking by Either Parent: 1.23 (1.14–1.33)a
Smoking by Both Parents: 1.42 (1.30–1.56)a
Maternal Smoking: 1.33 (1.24–1.43)a
Paternal Smoking: 1.07 (0.97–1.18)a
Bladder cancer Van Hemelrijck et al. [51] (Asia,
Europe, North America)
Case–controlCohort 8 223.000 Participants Childhood Exposure1.19 (0.88–1.62)b
Blood pressure Brion et al. [15] (Primary not given) Cohort 9 16.690 Participants Maternal Smoking During Pregnancy
Systolic Blood Pressure:0.67 mmHg (0.31 to
1.04)
Breast cancer Pirie et al. [52] (Asia, Europe, North
America)
Case–controlCohort 25 220.000 Participants Childhood Exposure: 0.98 (0.88–1.08)b
Childhood cancer
(overall)
Boffeta et al. [20] (Europe, North
America)
Case–control Cohort 12 900 participants
6351 cases
6253 controls
Maternal smoking during pregnancy1.10
(1.03–1.19)b
Cough Moritsugu et al. [12] (Europe, North
America, Australia, Asia, Africa)
39 Primary not given Cough
Smoking by either parent: 1.35 (1.27–1.43)a
Smoking by both parents: 1.64 (1.48–1.81)b
Maternal smoking: 1.34 (1.17–1.54)a
Paternal smoking: 1.22 (1.12–1.32)a
Cancer of the nervous
system (childhood)
Boffeta et al. [20] (Europe, North
America)
Case–control 12 Primary not given Maternal smoking during the pregnancy
1.04 (0.92–1.18)b
Case–control 10 1627 cases
2974 controls
Paternal smoking during pregnancy
1.22 (1.05–140)b
Genetic damage in
children
Neri et al. [19]
(Australia, Europe, USA, South
America)
Case–control
Cohort
6 Primary not given HB adducts
Children exposed to environmental tobacco
smoke: 1.38 (0.98–1.96)
5 Prenatal Exposure: 6.67 (2.56–17.24)
SCEe:prenatal exposure: 1.02 (0.94–1.10)d
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Lower respiratory
illnesses
Moritsugu et al. [12] (Europe, North
America, Australia, Asia, Africa)
Case–control
Cohort
38 Primary not given Lower respiratory illnesses
oking by either parent: 1.51 (1.44–1.59)a
aternal smoking: 1.56 (1.51–1.62)a
ternal smoking: 1.31 (1.20–1.42)a
Lower respiratory tract
infection
Li et al. [11] (Asia, Europe, North
America)
Case–control Cohort 13 32,945 cases ospitalisation for respiratory illness
93 (1.66–2.25)a
rious infections0–2 years: 1.71 (1.33–2.20)a
6 years: 1.25 (0.88–1.78)a
Lymphatic and
haematopoietic
Neoplasm (childhood)
Boffeta et al. [20]
(Europe, North America)
Case–control 9 Cases: 3610
Controls: 5054
aternal smoking during pregnancy 1.03
.90–1.17)
Kidney cancer
(childhood)
Boffeta et a. [20]
(Europe, North America)
Case–control 5 Cases: 442
Controls: 2536
aternal smoking during pregnancy
95 (0.76–1.19)
Middle ear effusion Moritsugu et al. [12]
(Europe, North America, Australia,
Asia, Africa)
6 Primary not given iddle ear effusion
oking by either parent: 1.20 (0.90–1.60)a
aternal smoking: 1.84 (1.54–2.20)a
ternal smoking: 1.49 (1.13–1.96)a
Non-Hodgkin
lymphoma (childhood)
Boffeta et al. [20]
(Europe, North America)
Case–control 4 Primary not given ternal smoking during the pregnancy
08 (1.08–3.98)b
Overweightf Oken et al. [32]
(Australia, Europe, North America)
Cohort 14 84,563 Participants aternal smoking during pregnancy
50 (1.36–1.65)a
Recurrent otitis media Moritsugu et al. [12]
(Europe, North America, Australia,
Asia, Africa)
9 Primary not given current otitis media
oking by either parent: 1.32 (1.14–1.52)a
aternal smoking: 1.37 (1.19–1.59)a
ternal smoking: 0.90 (0.70–1.15)a
Respiratory tract
infections
Peat et al. [13] (Asia, Australia, Chili,
Europe, New Zealand, USA)
Case–control Cohort 14 Primary not given rental smoking
ospitalisation for respiratory illness: 2a
wer respiratory tract infection: 1.7a
rly respiratory illness: 1.6a
Sudden infant death
syndrome
(after prone-sleep-
position intervention
programs)
Mitchell et al. [24]
(Europe, New Zealand, US)
Case–control
Cohort
24 Cases: 15,694
Controls: 3,592,021
Cases: 719
Controls: 4885
aternal smoking during pregnancy
93 (3.78–4.08)b
ternal smoking, mother does not smoke
49 (1.25–1.77)b
Wheeze Moritsugu et al. [12] (Europe, North
America, Australia, Asia, Africa)
45 heeze
oking by either parent: 1.26 (1.20–1.33)a
oking by both parents: 1.41 (1.23–1.63)a
aternal smoking: 1.28 (1.21–1.35)a
ternal smoking: 1.22 (1.12–1.32)a
a Odds ratio.
b Relative risk.
c PROM, premature rupture of membranes is a rupture (breaking open) of the membranes (amniotic sac) before labour begins. If PROM occur before 37 weeks of pregnancy, it is called preterm
premature rupture of membranes (PPROM).
d MR is a point estimate of the relative effect of the exposure on biomarker level detected in each study taking the value 1 when there is no e ect, values >1 when exposure is associated with a
decreased level of the investigated biomarker.
e SCE: sister chromatid exchange is the exchange of genetic material between two identical sister chromatids. The reason for the SCE is not know but it is required and used for mutagenic testing of
many products. Four to five sister chromatid exchanges are in the normal distribution, 14–100 exchanges are not normal and present a danger t the organism.
f Primary analysis of overweight has been chosen, defined as BMI P85th percentile or P90th percentile for age and sex.
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E J C S U P P L E M E N T S 1 1 ( 2 0 1 3 ) 2 4 2 –2 4 7 245of 10% (95%CI: 1.03–1.19) for childhood cancer, yet no signifi-
cant elevated risk was found for lymphomatic and haemato-
poietic neoplasm, or for cancer of the central nervous system
or kidney cancer (Table 1) [20]. When considering maternal
and paternal in-utero exposure to genotoxic compounds, a
difference in the mode of action is implied in the direct trans-
placental effects versus the preconception alterations. Car-
cinogens in tobacco can induce DNA damage in sperm:
male smokers have higher levels of 8-oxo-2-deoxyguanosine
in their semen than non-smokers, which may result in oxida-
tive damage to sperm DNA [21,22]. Paternal smoking during
conception and acute lymphoblastic leukaemia are related
with a pooled odds of 1.15 (CI: 1.06–1.24), paternal exposure
during pregnancy is not [20,23]. Furthermore, meta-analytical
work suggests an increased risk after paternal exposure to to-
bacco smoke with childhood non-Hodgkin lymphoma and tu-
mors in the central nervous system [20].
Based on pooled evidence of 25 studies [24], maternal
smoking was associated with almost a 4-fold time increase
in risk of sudden infant death syndrome. The corresponding
risk of paternal smoking with absence of maternal smoking
was 1.49 (Table 1). While the effect of smoke exposure in utero
seems to be stronger, postnatal environmental tobacco smoke
has been found to increase the risk of sudden infant death
syndrome even after controlling for prenatal exposure. How-
ever, in most cases this is difficult to distinguish as most chil-
dren that have been exposed in utero are also exposed during
their first months of life.
3. Smoking ban and health gains
The positive effect of smoking cessation suggests a causal asso-
ciation between active smoking and cardiovascular disease [25].
Evidence from observational studies shows a decrease in cardio-
vascular events in progression of atherosclerosis in those who
quit smoking compared with those continuing to smoke ciga-
rettes. Along with this, evidence from cohort studies and ecolog-
ical evidence on recent smoking bans (introduced by law)
consistently shows a rapid decrease in hospitalisation for myo-
cardial infarction (MI). The pooled aggregated data showed that
the rate of acute MI hospitalisation in countries that imple-
mented a smoking ban law, decreased 12months after its imple-
mentation, on average by 17% (95%CI: 20–13%) [26]. The rapid
decrease in MI after introduction of bans suggests an interplay
between chronic and acute processes, including triggers. A trig-
ger can be defined as an external stimulus that produces acute
physiological or pathophysiological changes. The idea of the
pathophysiological relevance of triggers leading to the onset of
acute myocardial infarction (MI) has been proposed [27]. In gen-
eral, ageing leads to functional and structural abnormalities of
the arterial wall, which are amplified by hypertension and ath-
erosclerosis [28]. A vulnerable atherosclerotic plaque might lead
to an occlusive thrombus which is more likely to be formed if
other factors come into play to narrow homoeostasis and in-
crease vasoconstriction. The role of triggers such as alcohol
[29], anger [30,31], physical exertion [31,32]and use of marijuana
[33] in the onset of MI is recognised [34].
Recently gained evidence supports the notion that prema-
ture birth is also a syndrome which might have trigger com-
ponents, including ambient temperature and smoking[35,36]. Recent Scottish [36] and Belgian [35] data support
reductions in the rate of preterm births after the implementa-
tion of smoking bans, whereas no such decrease was evident
in the years or months before these bans.
In Belgium, smoke-free legislation was implemented in dif-
ferent phases (in public places and most workplaces in January
2006, in restaurants January 2007, and in bars serving food Jan-
uary 2010). Wewere able to demonstrate a consistent pattern of
changes in preterm delivery with stepwise reductions over the
different enforcements. In an analysis using a birth register
comprising 606,877 live-births, we observed an immediate
change in the risk of spontaneous preterm delivery of 3.13%
(95%CI: 4.37% to 1.87%; P < 0.01) on 1st January 2007 (ban
on smoking in restaurants), and an annual slope change of
2.65% (5.11% to 0.13%; P = 0.04) after 1st January 2010
(ban on smoking in bars serving food). In 716,941 Scottish new-
borns, the risk was decreased by 11.72% (95% CI: –15.87 to –7.35)
3 months prior to the introduction of the comprehensive smok-
ing ban in 2006. Similarly to Belgian findings, a study on the im-
pact of the Irish workplace smoking ban on birth weight and
preterm birth found a protective effect only on the latter out-
come [37]. Although their analysis was limited to a comparison
of rates 1 year before and after the ban, they even found an in-
crease in the risk of low birth weight.
The smoking ban studies must be viewed as an investiga-
tion of the possible impact of a ‘population intervention’
rather than an investigation of changes in individual behav-
iour. It is possible that unmeasured confounders were respon-
sible for the observed changes. Nevertheless, it is hard to
conceive of a factor that could change the population risk of
preterm births after the introduction of the different succes-
sive smoking bans. It is unlikely that our observations could
be explained by abrupt changes in therapeutic strategies coin-
ciding with the smoking bans. Nevertheless, the Belgian study
collected data on the prescription of atosiban and on cervical
cerclage treatment from a social security organisation cover-
ing 42% of the population. Atosiban is an inhibitor of oxytocin
and vasopressin and is specifically used to halt premature la-
bour. Cervical cerclage is used for the treatment of cervical
incompetence, a condition where the cervix has opened
slightly and there is a risk of miscarriage.
Given that even a mild reduction in gestational age has
been linked to adverse health outcomes in early and later life,
these population interventions have important public health
implications. Indeed, a Swedish study found that, even
among those born late preterm (34–36 weeks), preterm birth
was associated with a 31% (13–50%) increase in mortality in
young adulthood [38].4. Molecular epidemiological aspects
The human placenta forms the interface between foetal and
maternal circulation, and by controlling nutrient supply plays
a critical role in the regulation of foetal growth and develop-
ment. Maternal smoking causes perturbations in this utero-
placental exchange as it increases the risk of low birth weight
[39,40] and preterm delivery [35,41]. The mechanisms under-
lying these observed effects remain unclear, but emerging
data suggest that biochemical, genetic and epigenetic activi-
246 E J C S U P P L E M E N T S 1 1 ( 2 0 1 3 ) 2 4 2 –2 4 7ties respond to and are modified by in-utero tobacco expo-
sure. Nutrients and potential pollutants are metabolised,
making the placenta a molecular ‘footprint’ to which the foe-
tus has been exposed in utero.
Mitochondria are abundant in placental cells, they provide
energy for the functioning of this metabolically active organ.
Each cell contains approximately 200–2000 mitochondria, car-
rying between two and ten copies of mitochondrial DNA
(mtDNA). Recently, by assessing the relative mtDNA content
(a marker of mitochondrial damage and dysfunction), its
functioning has been linked to various disease mechanisms
[42,43]. The placental mtDNA content has been shown to be
very adaptive to environmental insults, including maternal
smoking [44] and air pollution [45]. The relative mtDNA con-
tent is decreased by 37% (P < 0.02) in placentas of mothers
who smoke [44] compared with a decrease of 17.4% (P = 0.05)
for each 10-lg/m3 increase in PM10 exposure during the third
trimester of pregnancy [45].
Important questions remain concerning how mitochondrial
biogenesis and maintenance are regulated as a response to to-
bacco exposures, and how these relate to placental functioning.
An attractive link between adverse insults and altered foetal
development is gene regulation. Maternal smoking during preg-
nancy can lead to changed placental gene expression levels,
which is epigenetically regulated by DNA methylation, histone
modifications or non-coding RNAs. Epigenetic changes can occur
throughout the course of life as a result of environmental condi-
tions. Much of the epigenome is already established in germ cells
and embryos as it appears to be particularly important for the
regulation of embryonic growth and placental development
[46]. Recently, studies investigating cord blood and placental tis-
sue showed that the epigenetic system is sensitive to tobacco
exposure in utero. Global DNA methylation levels in cord blood
is lower among newborns with smoking mothers
(mean = 15.04%; 95%CI: 8.4–21.7) compared with second-hand
smokers (21.1%; 95%CI: 16.6, –25.5) and their non-smoking coun-
terparts (mean = 29.2%; 95%CI: 20.1–38.1) [47]. An epigenome-
widemethylation study in cord blood of newborns exposed to to-
bacco smoke during pregnancy showed that genes that play an
important role in detoxifying components of tobacco smoke
(AHRR and CYP1A1) are differentially methylated [48]. Accord-
ingly, Suter and colleagues reported site-specific changes in
DNA methylation of the CYP1A1 promoter, and this hypomethy-
lation correlated with an increase in CYP1A1 gene expression in
the placenta [49]. They showed in an epigenome-wide methyla-
tion study on placental tissue that methylation levels of 623
genes are deregulated in a CpG site-specific manner [50].
Despite a limited number of (epi)genomic studies in cord
blood and placental tissue, we are getting a better picture of
how maternal tobacco smoke can alter placental functioning
and contribute to adverse pregnancy outcomes. Therefore the
potential health consequences of changes in mitochondrial
functioning, gene expression and epigenetics in early life
should be further elucidated.Conflict of interest statement
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